Danger of E-Cigarettes: Official Warning in Kazakhstan

Regulations by 2FIRSTS.ai
Nov.22.2023
Danger of E-Cigarettes: Official Warning in Kazakhstan
Kazakhstan issues warning on dangers of e-cigarettes, including potential lung diseases and physical injuries from explosions and burns.

According to a report by Kazakhstani media outlet YCTNHKA LIVE on November 22nd, Kazakhstan has issued a warning about the dangers of e-cigarettes.

 

The department states that e-cigarettes may lead to serious lung diseases, cardiovascular disorders, and physical injuries, such as burn injuries caused by explosions and malfunctions.

 

The department pointed out that when heating e-liquid in e-cigarettes, which contains ingredients such as propylene glycol, glycerin, nicotine, and flavorings, a chemical reaction may occur, potentially resulting in the production of new chemical substances. When these substances enter lung tissues, they may cause damage to the pulmonary system and even have fatal consequences.

 

The danger of smoking e-cigarettes lies in nicotine itself, which may have a concentration that exceeds that of regular cigarettes by up to ten times.

 

According to statistical data, 9.8% of teenagers between the ages of 11 and 15 in Kazakhstan use e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Judge Dismisses Some Claims in Arkansas THC Vape Class Action
Judge Dismisses Some Claims in Arkansas THC Vape Class Action
U.S. District Judge Brian S. Miller has dismissed some claims from a proposed class action alleging that vape products contained THC levels above legal limits, while allowing others to proceed. The court rejected warranty and drug liability claims but upheld RICO, negligence, and fraud allegations against multiple defendants.
Nov.11 by 2FIRSTS.ai
The Mumbai Criminal Investigation Department in India seized about $40,000 worth of smuggled e-cigarettes and arrested one suspect
The Mumbai Criminal Investigation Department in India seized about $40,000 worth of smuggled e-cigarettes and arrested one suspect
The Mumbai Criminal Investigation Department (CID) in India seized a batch of smuggled e-cigarettes worth approximately 3.2 million rupees (approximately $40,000) and arrested a suspect, Ravindra Kishore Dedia. The suspect is currently being questioned, and police are tracking down other members of the smuggling network.
Sep.29 by 2FIRSTS.ai
British American Tobacco France: A complete ban on tobacco-free nicotine pouches could drive the expansion of the black market
British American Tobacco France: A complete ban on tobacco-free nicotine pouches could drive the expansion of the black market
British American Tobacco (BAT) France expressed opposition to the government's plan to ban tobacco-free nicotine pouches in the National Assembly, arguing that a ban would foster a vibrant black market and harm public health and the protection of minors. The company also cited the examples of Sweden and New Zealand, which have reduced smoking rates through "clear regulations and strict controls," and proposed three policy recommendations: ban sales to minors, strictly regulate smokeless nicotine
Sep.26 by 2FIRSTS.ai
Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products
Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products
The Santa Fe Provincial Chamber of Deputies has passed a bill amending the 2005 Provincial Anti-Smoking Law (No. 12,432) to include e-cigarettes, vaping devices, and heated tobacco products. Lawmaker Sonia Martorano, who authored the initiative, said the reform aims to strengthen prevention policies amid growing youth use, stressing that “even without nicotine, these devices are toxic.”
Nov.05 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales
PMI Q3 2025 Earnings: Net Revenues Reach $10.85 Billion, Smoke-Free Products Account for 41% of Sales
PMI reported strong third-quarter 2025 results, underscoring the continued success of its smoke-free transformation. Net revenues rose 9.4% year-over-year to $10.85 billion, driven by robust growth in the smoke-free segment, which now accounts for 41% of total net revenues and over 42% of gross profit.Despite a 3.2% decline in cigarette shipments, combustible revenues climbed 4.3% thanks to strong pricing.
Oct.21